Giorgio Ballardini

Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial

Paolo Caraceni, Oliviero Riggio, Paolo Angeli et al. · The Lancet · 2018 · 499 citations · Full text

Hepatology, Decompensated Cirrhosis, Liver Physiology +6

ABERRANT EXPRESSION OF HLA-DR ANTIGENS ON BILEDUCT EPITHELIUM IN PRIMARY BILIARY CIRRHOSIS: RELEVANCE TO PATHOGENESIS

Giorgio Ballardini, FrancescoB. Bianchi, Deborah Doniach et al. · The Lancet · 1984 · 498 citations

Hepatology, Biliary Tract, Biliary Cancer +14

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial

Olga Vaccaro, Maria Masulli, Antonio Nicolucci et al. · The Lancet Diabetes & Endocrinology · 2017 · 285 citations

Diabetes Management, Cardiovascular Disease, Diabetes +9

Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity

Marco Lenzi, Giorgio Ballardini, Francesco B. Bianchi et al. · The Lancet · 1991 · 203 citations

Autoimmune Disease, Hepatitis C, Hepatology +13

Desmin and actin in the identification of Ito cells and in monitoring their evolution to myofibroblasts in experimental liver fibrosis

Giorgio Ballardini, M Fallani, G. Biagini et al. · Virchows Archiv B Cell Pathology Including Molecular Pathology · 1988 · 152 citations